Aurora Cannabis (ACB) Operating Expenses (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Operating Expenses of $18.7 million for Q1 2026, up 31.0% year-on-year from $14.3 million in Q1 2025, and down 3.4% on a QoQ basis from $19.4 million in Q4 2025.
Aurora Cannabis (ACB) Operating Expenses (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Operating Expenses for 10 consecutive years, with $18.7 million the latest figure, recorded in Q1 2026.
- Quarterly Operating Expenses rose 31.0% year-over-year to $18.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.0 million (down 91.21% YoY) and the FY2026 annual result came in at $132.6 million, up 8.14% from the prior year.
- Operating Expenses declined to $18.7 million in Q1 2026 per ACB's latest filing, from $19.4 million in the prior quarter.
- Over the last five years, Operating Expenses for ACB reached as high as $1.2 billion in Q3 2023 and fell as low as -$47.6 million in Q2 2024.
- A 5-year average of $161.6 million and a median of $20.6 million in 2025 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2023 — Operating Expenses jumped 3020.64% — and 2024, when it sank 130.15%.
- Year by year, Operating Expenses stood at $40.8 million in 2022, then slumped by 57.25% to $17.5 million in 2023, then grew by 5.42% to $18.4 million in 2024, then grew by 5.44% to $19.4 million in 2025, then retreated by 3.4% to $18.7 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $18.7 million, $19.4 million, and $20.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 18.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.74 Mn |
| Dec 31, 2025 | 19.40 Mn |
| Sep 30, 2025 | 20.61 Mn |
| Jun 30, 2025 | 21.26 Mn |
| Mar 31, 2025 | 14.31 Mn |
| Dec 31, 2024 | 18.40 Mn |
| Sep 30, 2024 | 925.00 Mn |
| Jun 30, 2024 | -47.64 Mn |
| Mar 31, 2024 | 18.41 Mn |
| Dec 31, 2023 | 17.46 Mn |
| Sep 30, 2023 | 1.25 Bn |
| Jun 30, 2023 | 158.00 Mn |
| Dec 31, 2022 | 40.83 Mn |
| Sep 30, 2022 | 39.96 Mn |
| Jun 30, 2022 | 53.56 Mn |
| Mar 31, 2022 | 20.57 Mn |
| Dec 31, 2021 | 48.69 Mn |
| Sep 30, 2021 | 51.50 Mn |
| Jun 30, 2021 | 31.61 Mn |
| Mar 31, 2021 | 24.58 Mn |